Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J. Short, Elias Jabbour, Hagop M. Kantarjian et al.|Blood|2021Cited by 26
Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II StudyNicholas J. Short, Elias Jabbour, Hagop M. Kantarjian et al.|Blood|2020Cited by 20
Determination and distribution of left ventricular size as measured by noncontrast CT in the Multi-Ethnic Study of AtherosclerosisWaqas Qureshi, Matthew J. Budoff, Roger S. Blumenthal et al.|Journal of cardiovascular computed tomography|2015Cited by 10